Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04375956
Title Study on Pembrolizumab in Recurrent, Platinum Resistant, CPS >1 Positive Ovarian, Fallopian Tube and Primary Peritoneal Cancer Patients (MITO 27)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Indications

ovarian cancer

peritoneum cancer

fallopian tube cancer

Therapies

Pembrolizumab

Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.